Health Product Shortages homepage

Welcome to Health Product Shortages Canada, the website for mandatory reporting of health product shortages and discontinuations by regulated parties. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the health products they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca (open in new tab).

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

List of shortage reports
Brand name Company Name Status Strength Update Date Updated View Report
!T3 GLUCAGON ELI LILLY CANADA INC Anticipated shortage 1MG Updated Report 2026-01-05 257928
GLUCAGON ELI LILLY CANADA INC Actual shortage 1MG New Report 2026-01-05 257924
LEVOFLOXACIN IN 5% DEXTROSE INJECTION HIKMA CANADA LIMITED Actual shortage 5MG New Report 2025-12-31 257921
TAPAZOLE ENDO OPERATIONS LTD. Anticipated shortage 5MG New Report 2025-12-08 257907
ARIMIDEX ASTRAZENECA CANADA INC Actual shortage 1MG New Report 2025-12-04 257901
ARIMIDEX ASTRAZENECA CANADA INC Actual shortage 1MG New Report 2025-12-04 257898
JAMP-ANASTROZOLE JAMP PHARMA CORPORATION Actual shortage 1MG Updated Report 2025-12-04 246759
ENHERTU ASTRAZENECA CANADA INC Actual shortage 100MG New Report 2025-12-03 257856
ARIMIDEX ASTRAZENECA CANADA INC Actual shortage 1MG Updated Report 2025-12-03 257848
ANASTROZOLE SIVEM PHARMACEUTICALS ULC Actual shortage 1MG Updated Report 2025-12-02 217977

Discontinuation Reports

List of discontinuation reports
Brand name Company Name Status Strength Update Date Updated View Report
!T3 GLUCAGON ELI LILLY CANADA INC To be discontinued 1MG New Report 2026-01-05 257931
ARIMIDEX ASTRAZENECA CANADA INC To be discontinued 1MG New Report 2025-12-04 257904
SYNAGIS ASTRAZENECA CANADA INC To be discontinued 50MG New Report 2025-12-04 257886
SYNAGIS ASTRAZENECA CANADA INC To be discontinued 50MG New Report 2025-12-04 257882
SYNAGIS ASTRAZENECA CANADA INC Discontinued 100MG New Report 2025-12-04 257874
Get it on Google Play Download on the App Store